Oct 12, 2023 7:00am EDT XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution
Sep 28, 2023 7:00am EDT XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023
Aug 29, 2023 7:00am EDT XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease